You are here

  • Home
  • Archive
  • Volume 70, Issue 7
  • The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis

Article Text

Article menu
Download PDFPDF
Letters
The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis

https://doi.org/10.1136/ard.2010.146878

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval The administration of canakinumab was approved by the Scientific Council of University General Hospital of Alexandroupolis and the Greek National Organization for Medicines (EOF).

    • Provenance and peer review Not commissioned; externally peer reviewed.